Plain-English translation of NCT07132333 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study — meaning researchers watch and document what happens in everyday clinical care rather than testing a new drug. If you have psoriasis, psoriatic arthritis, inflammatory bowel disease, or spondylarthropathy, and you're being seen at one of four German university hospitals for treatment planning, this study invites you to allow your medical team to track your progress and outcomes as part of routine care.
Doctors increasingly tailor inflammation treatments to each patient's unique biology, but there is limited real-world data on how well these personalized plans work and whether patients actually follow the recommendations. This study aims to collect that missing information so doctors can improve their approach to caring for patients with chronic inflammatory diseases.
You likely qualify if…
You likely don't qualify if…
You would continue your regular appointments at your hospital's inflammation center as usual. The research team would collect information from your medical records, including your symptoms, test results, and how well your treatment is working. You would also complete surveys or questionnaires about how you're feeling and how your condition affects your daily life. This is part of your normal care — not extra visits — and helps doctors understand what works best for patients like you.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Germany
Sponsor
University Hospital Tuebingen
Collaborators
University Hospital Freiburg, University Hospital Heidelberg
Enrollment target
~3,000 participants
Started
November 2022
Primary completion
November 2032
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nisar P Malek, Prof. Dr.
University Hospital Tuebingen
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.